← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2011Last known activity
Dec 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03038490Reponsible party - principal investigatorN/ADec 1, 2016
- NCT03038490Lead sponsorN/ADec 1, 2016
- NCT01315977CollaboratorPhase 1/Phase 2Feb 1, 2011
Details
- Last known activity
- Dec 1, 2016